The predictors of pelvic lymph node metastasis at radical retropubic prostatectomy

Journal of Urology

Volumn 170, Issue 6 I, 2003, Pages 2306-2310

  Naya, Yoshio ^b   Babaian, R Joseph ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

Lymph node excision; Patient selection; Prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ALGORITHM; ARTICLE; CANCER GRADING; CANCER STAGING; CHI SQUARE TEST; CLASSIFICATION AND REGRESSION TREE ANALYSIS; GLEASON SCORE; HAMBURG ALGORITHM; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PELVIS LYMPH NODE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RANK SUM TEST; STATISTICAL ANALYSIS;

EID: 0242608520     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000097180.98966.06     Document Type: Article

References (20)

1. Wolf, J. S., Jr., Cher, M., Dall'era, M., Presti, J. C., Jr., Hricak, H. and Carroll, P. R.: The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol, 153: 993, 1995
2. Hammerer, P., Huland, H. and Sparenberg, A.: Digital rectal examination, imaging and systematic-sextant biopsy in identifying operable lymph node-negative prostatic carcinoma. Eur Urol, 22: 281, 1992
3. Partin, A. W., Pound, C. R., Clements, J. Q., Epstein, J. I. and Walsh, P. C.: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am, 20: 713, 1993
4. Gervasi, L. A., Mata, J., Easley, J. D., Wilbanks, J. H., Seale-Hawkins, C., Carlton, C. E., Jr. et al: Prognostic significance of lymph nodal metastases in prostate cancer. J Urol, 142: 332, 1989
5. Johnson, D. E. and von Eschenbach, A. C.: Roles of lyphangiography and pelvic lymphadectomy in staging prostate cancer. Urology, suppl., 17: 66, 1981
6. McDowell, G. C., 2nd, Johnson, J. W., Tenney, D. M. and Johnson, D. E.: Pelvic lymphadenectomy for staging clinically localized prostate cancer. Indications, complications, and results in 217 cases. Urology, 35: 476, 1990
7. Han, M., Partin, A. W., Piantadosi, S., Epstein, J. I. and Walsh, P. C.: Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J Urol, 166: 416, 2001
8. Conrad, S., Graefen, M., Pichlmeier, U., Henke, R.-P., Hammerer, P. G. and Huland, H.: Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastasis in patients with clinically localized prostate carcinoma. J Urol, 159: 2023, 1998
9. Steinberg, D. and Colla, P.: CART-Classification and Regression Trees. San Diego: Salford Systems, 1997
10. Han, M., Snow, P. B., Brandt, J. M. and Partin, A. W.: Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma. Cancer, suppl., 91: 1661, 2001
11. Partin, A. W., Kattan, M. W., Subong, E. N., Walsh, P. C., Wonjo, K. J., Oesterling, J. E. et al: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA, 277: 1445, 1997
12. Danella, J. F., deKernion, J. B., Smith, R. B. and Steckel, J.: The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection. J Urol, 149: 1488, 1993
13. Bluestein, D. L., Bostwick, D. G., Bergstralh, E. J. and Oesterling, J. E.: Eliminating the need for bilateral pelvic lymphadectomy in select patients with prostate cancer. J Urol, 151: 1315, 1994
14. Parra, R. O., Isorna, S., Perez, M. G., Cummings, J. M. and Boullier, J. A.: Radical perineal prostatectomy without pelvic lymphadenectomy: selection criteria and early results. J Urol, 155: 612, 1996
15. Narayan, P., Fournier, G., Gajendran, V., Leidich, R., Lo, R., Wolf, J. S., Jr. et al: Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Urology, 44: 519, 1994
16. Bishoff, J. T., Reyes, A., Thompson, I. M., Harris, M. J., St. Clair, S. R., Gomella, L. et al: Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology, 45: 270, 1995
17. Conrad, S., Graefen, M., Pichlmeier, U., Henke, R.-P., Erbersdobler, A., Hammerer, P. G. et al: Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostate carcinoma. J Urol, 167: 521, 2002
18. Haese, A., Epstein, J. I., Huland, H. and Partin, A. W.: Validation of a biopsy-based pathologic algorithm for predicting lymph node metastasis in patients with clinically localized prostate carcinoma. Cancer, 95: 1016, 2002
19. Tewari, A. and Narayan, P.: Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks. J Urol, 160: 430, 1998
20. Batuello, J. T., Gamito, E. J., Crawford, E. D., Han, M., Partin, A. W., McLeod, D. G. et al: Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer. Urology, 57: 481, 2001